The extent of the bladder cancer — how far it has spread — matters. Your care team needs to know if your cancer sits on or in the first lining of your bladder (non-muscle invasive), if it goes into ...
Non-muscle invasive bladder cancer is cancer that’s only in the inner lining of your bladder. It hasn’t grown into the muscle wall. Your doctor may also call it superficial bladder cancer, urothelial ...
Phase 1 data show that Erda-iDRS, an intravesical erdafitinib delivery system, achieved an 89% complete response rate in FGFR-altered intermediate-risk non–muscle-invasive bladder cancer, with a ...
Overall survival appears no worse for patients with organ-confined limited-stage small cell bladder cancer receiving multimodal organ-preserving treatment. For patients with limited-stage small-cell ...
Diagnostic test based on urinary tumor markers hold promise for earlier or prompt detection of bladder cancer in patients ...
Hosted on MSN
Does TARA stock’s 15% after-hours slump signal a bargain after new bladder cancer data?
・The company reported strong efficacy and a clean safety profile from its ongoing Phase 2 Advanced-2 bladder cancer trial. ・Durability signals were notable, with 68% of BCG-unresponsive patients and ...
How Do Cancer Survivors Fare After Lung Cancer Screening? Among patients undergoing first-time lung cancer screening, cancer survivors may have a slightly higher cancer detection rate. Medscape ...
Results of two phase 3 studies — IMvigor011 and DYNAMIC-III — presented at the European Society for Medical Oncology (ESMO) Annual Meeting 2025 suggest that circulating tumor DNA (ctDNA) could help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results